AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimter MV 2mg/500mg/0.2mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Bluewaterresearch

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Glimter MV 2mg/500mg/0.2mg Tablet SR

Diabex Trio 2mg/500mg/0.2mg Extended-Release Tablets are classified as antidiabetic medications. This combination drug treats type 2 diabetes in adults by regulating blood glucose. Diabex Trio should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continuous use is crucial, even with controlled blood sugar, as premature cessation can lead to elevated glucose levels, potentially causing kidney damage, vision loss, neuropathy, and limb complications. Remember, this medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle modifications are integral to diabetes control. Hypoglycemia (low blood sugar) is the most frequent adverse effect, manifested by sweating, dizziness, headache, and tremors. Recognize these symptoms and know how to counteract them with a fast-acting glucose source (e.g., sugary snacks, fruit juice). Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Other possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. Do not use if you have type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Disclose any history of heart disease to your doctor before commencing treatment, as it may be contraindicated. Pregnant or lactating individuals should seek medical advice prior to use. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are recommended by your physician.

Uses of Glimter MV 2mg/500mg/0.2mg Tablet SR

Managing type 2 diabetes

Major Benefits of Glimter MV 2mg/500mg/0.2mg Tablet SR:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the entire tablet without chewing, crushing, or dividing it. Consume Glimter MV 2mg/500mg/0.2mg Extended-Release Tablets on an empty stomach.

Common Side effects of Glimter MV 2mg/500mg/0.2mg Tablet SR:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Glimter MV 2mg/500mg/0.2mg Tablet SR:

Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Glimter MV 2mg/500mg/0.2mg Extended-Release tablets on an empty stomach.

How Glimter MV 2mg/500mg/0.2mg Tablet SR works:

Glimter MV extended-release tablets (2mg/500mg/0.2mg) contain a triple-drug formulation for diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimter MV 2mg/500mg/0.2mg Tablet SR with alcohol is dangerous.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Glimter MV 2mg/500mg/0.2mg tablet may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing this medication. Patient consultation with their doctor is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Prolonged-release Glimter MV tablets (2mg/500mg/0.2mg) are likely unsuitable for breastfeeding mothers. Available evidence in humans indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyUNSAFE

The use of Glimter MV 2mg/500mg/0.2mg SR tablets is likely unsafe for individuals with kidney impairment and should be omitted. Medical advice is recommended. Furthermore, this medication is contraindicated in patients exhibiting severe kidney dysfunction.

LiverLiverCAUTION

Patients with liver impairment should use Glimter MV 2mg/500mg/0.2mg SR tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. Low initial doses are generally recommended for individuals with mild to moderate liver disease; however, the medication is contraindicated in those with severe hepatic dysfunction.

What if you forget to take Glimter MV 2mg/500mg/0.2mg Tablet SR :

Should you forget to take your Glimter MV 2mg/500mg/0.2mg Tablet SR, ingest it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.

Facts to Know About Glimter MV 2mg/500mg/0.2mg Tablet SR

LabelValue
Potential for Dependence None.
Type of Medication Medication for diabetes

FAQs on Glimter MV 2mg/500mg/0.2mg Tablet SR

The extended-release tablet Glimter MV 2mg/500mg/0.2mg combines glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus in adults. This medication, used alongside a healthy diet and exercise regimen, helps regulate blood sugar. Glimepiride stimulates pancreatic insulin secretion, reducing blood glucose. Metformin decreases hepatic glucose production and enhances insulin responsiveness. Voglibose, an alpha-glucosidase inhibitor, reduces post-meal glucose spikes. This formulation is unsuitable for type 1 diabetes.
Taking Glimter MV 2mg/500mg/0.2mg SR tablets may cause common side effects including low blood sugar, nausea, diarrhea, changes in taste perception, gas, abdominal pain, headache, skin rashes, and respiratory infections.
Patients with hypersensitivity to any constituent or inactive ingredient in Glimter MV 2mg/500mg/0.2mg Tablet SR should not take this medication. This medicine is contraindicated in individuals with moderate to severe renal impairment, and those with inflammatory bowel disease, colonic ulcers, or underlying metabolic acidosis, such as diabetic ketoacidosis.
Combining Glimter MV 2mg/500mg/0.2mg SR tablets with alcohol is unsafe. This combination can lead to dangerously low blood sugar (hypoglycemia) and a heightened risk of lactic acidosis.
Glimter MV 2mg/500mg/0.2mg SR tablets can induce hypoglycemia. Low blood sugar symptoms may include nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremor. These symptoms are more likely if meals are skipped or delayed, alcohol is consumed, excessive exercise is undertaken, or concomitant antidiabetic medications are used. Consequently, consistent blood glucose monitoring is crucial. Always carry readily available glucose sources such as glucose tablets, honey, or fruit juice.
Retain this medication in its original, sealed packaging. Follow the storage directions provided on the packaging or label. Discard any leftover medication. Ensure it remains inaccessible to children, pets, and others.
Glimter MV 2mg/500mg/0.2m...
98
MRP 120
18% off